From Compliance Burden to Strategic Capability
As global regulations continue to evolve, life sciences organizations face increasing pressure to meet stringent compliance expectations without slowing innovation or compromising product quality. The...
Read MoreSustaining Reliability: Life Cycle Maintenance of AI Models in Drug Development (Part 2 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read MoreInnovative Approaches to Quality and Engineering Management: Transforming Life Sciences Manufacturing
The path to operational excellence is continually being redefined. Today’s manufacturers face mounting pressure to enhance product quality, improve compliance, and optimize operational efficiency—all while...
Read MoreFDA Quality Management Maturity Program
Drug shortages in the pharmaceutical industry is a significant concern that has far-reaching consequences for the industry, the regulators, the healthcare system, and ultimately the...
Read More